Covered recipient · General Payments record
SETH S MARTIN
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2024
$167,821.54
- Reported across 132 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $40,258.50 | 9 |
| Travel and Lodging | $1,361.37 | 4 |
| Food and Beverage | $1,208.83 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| HEARTFLOW, INC. | $24,403.77 | 9 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $9,929.47 | 3 |
| Merck Sharp & Dohme Corporation | $6,773.87 | 8 |
| Amgen Inc. | $1,595.30 | 6 |
| Novo Nordisk AS | $99.78 | 1 |
| Regeneron Pharmaceuticals, Inc. | $26.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $92.58 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117620972 | CMS |
| Amgen Inc. | $80.35 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117620974 | CMS |
| Amgen Inc. | $30.22 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117620976 | CMS |
| Amgen Inc. | $136.98 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117620978 | CMS |
| Amgen Inc. | $124.17 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117620980 | CMS |
| Amgen Inc. | $1,131.00 | 12/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117620982 | CMS |
| HEARTFLOW, INC. | $3,500.00 | 07/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1154173143 | CMS |
| HEARTFLOW, INC. | $31.48 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154172807 | CMS |
| HEARTFLOW, INC. | $13.69 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154172809 | CMS |
| HEARTFLOW, INC. | $100.00 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154172811 | CMS |
| HEARTFLOW, INC. | $108.60 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154172813 | CMS |
| HEARTFLOW, INC. | $700.00 | 08/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1154173145 | CMS |
| HEARTFLOW, INC. | $2,100.00 | 09/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1154173147 | CMS |
| HEARTFLOW, INC. | $15,050.00 | 10/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1154173149 | CMS |
| HEARTFLOW, INC. | $2,800.00 | 11/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1154173151 | CMS |
| Merck Sharp & Dohme LLC | $371.48 | 10/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1141647764 | CMS |
| Merck Sharp & Dohme LLC | $468.41 | 10/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1141647770 | CMS |
| Merck Sharp & Dohme LLC | $371.48 | 10/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1141647762 | CMS |
| Merck Sharp & Dohme LLC | $150.00 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141647766 | CMS |
| Merck Sharp & Dohme LLC | $30.00 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141647772 | CMS |
| Merck Sharp & Dohme LLC | $55.00 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141854495 | CMS |
| Merck Sharp & Dohme LLC | $150.00 | 10/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1141647768 | CMS |
| Merck Sharp & Dohme LLC | $5,177.50 | 10/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141647774 | CMS |
| Novartis Pharmaceuticals Corporation | $129.47 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087110640 | CMS |
| Novartis Pharmaceuticals Corporation | $4,900.00 | 09/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1087150442 | CMS |
| Novartis Pharmaceuticals Corporation | $4,900.00 | 11/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1087150444 | CMS |
| Novo Nordisk Inc | $99.78 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096932075 | CMS |
| Regeneron Pharmaceuticals, Inc. | $26.51 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114402461 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.